A provider briefing on the Aquasol E shortage in 2026. Shortage timeline, prescribing implications, alternative formulations, and tools to help patients.
The shortage of Aquasol E (vitamin E / d-alpha tocopherol aqueous oral solution) continues to impact clinical practice in 2026. For providers who prescribe liquid vitamin E for premature infants, patients with cystic fibrosis, or those with fat-malabsorption syndromes, the ongoing unavailability of this product presents real challenges in patient management.
This article provides a concise briefing on the current state of the Aquasol E shortage, the clinical implications for your prescribing decisions, and practical resources to help your patients access vitamin E supplementation.
The Aquasol E shortage has developed over several years through a series of manufacturer exits and supply chain disruptions:
The capsule and softgel forms of vitamin E remain widely available through OTC channels. The shortage is specific to the aqueous oral solution/liquid drops formulation.
The clinical significance of this shortage varies by patient population:
Premature infants requiring vitamin E supplementation represent the most vulnerable population affected by this shortage. These patients cannot take capsules and may have limited enteral absorption capacity. The water-soluble liquid formulation is often medically necessary for adequate bioavailability.
Clinical consideration: When prescribing for neonates, consider compounded aqueous vitamin E solutions as the primary alternative. Coordinate with your hospital pharmacy or a compounding pharmacy experienced in pediatric formulations.
Cystic fibrosis patients with pancreatic insufficiency have well-documented fat-malabsorption that affects vitamin E status. CF Foundation guidelines recommend vitamin E supplementation, with doses ranging from 40-50 IU/day in infants to 200-400 IU/day in patients over 8 years.
Clinical consideration: Aqua-E (a water-soluble vitamin E liquid with mixed tocopherols and tocotrienols) is the closest commercially available alternative. For patients who can tolerate capsules and are receiving adequate pancreatic enzyme replacement therapy (PERT), standard vitamin E capsules with meals may provide sufficient absorption.
Patients with intestinal disease, liver disease, cholestatic conditions, or post-gastrectomy status may require supplemental vitamin E in a water-soluble form. Assess each patient's absorptive capacity individually when selecting an alternative formulation.
For patients with documented vitamin E deficiency who do not have fat-malabsorption, OTC vitamin E capsules (d-alpha tocopherol 200-400 IU daily) remain readily available and therapeutically equivalent.
As of March 2026:
Important points for prescriber awareness:
For a detailed patient-facing resource on saving money, you can direct patients to: How to Save Money on Aquasol E in 2026.
Several resources can help you and your patients navigate the shortage:
Medfinder offers a pharmacy inventory search tool that helps locate pharmacies with Aquasol E or vitamin E liquid products in stock. You can recommend this tool to patients or use it in your practice to assist with prescription routing.
Monitor the ASHP drug shortage list for updates on vitamin E aqueous oral solution availability and any new manufacturer announcements.
Develop relationships with local compounding pharmacies experienced in preparing pediatric and specialty formulations. Having a preferred compounding partner streamlines the process when commercial products are unavailable.
For a step-by-step approach to helping patients find Aquasol E, see our companion article: How to Help Your Patients Find Aquasol E in Stock: A Provider's Guide.
The Aquasol E shortage is unlikely to resolve quickly given the lack of new manufacturers entering the market. Providers should:
While the Aquasol E shortage presents ongoing challenges, informed prescribing and proactive patient communication can minimize clinical impact. The key is matching the alternative to the patient's specific clinical need — particularly distinguishing between patients who genuinely require water-soluble liquid vitamin E and those who can safely use standard capsules.
For additional clinical resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
